HL Deb 17 February 2003 vol 644 c156WA
Lord Ashley of Stoke

asked Her Majesty's Government:

Whether they will encourage the National Institute for Clinical Excellence to assess the medical drug Ebixa for use by patients with Alzheimer's disease; and [HL1544]

What discussion they have had, or intend to have, with the Alzheimer Society about the use of Ebixa for patients with Alzheimer's disease. [HL1545]

Lord Hunt of Kings Heath

The Government are currently considering whether the National Institute for Clinical Excellence (NICE) should appraise memantine (Ebixa) as part of its eighth wave of work.

The Alzheimer's Society has put its views to the Government about the use of memantine for people with Alzheimer's disease.